Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 14/20 | 0.68 |
| ▸ | DGAT1 | O75907 | 6/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18359218 | 0.89 | DGAT1 (0.70) | FOLH1DGAT1 | |
| SCHEMBL29293807 | 0.88 | DGAT1 (0.64) | FOLH1DGAT1 | |
| SCHEMBL19248267 | 0.88 | DGAT1 (0.64) | FOLH1DGAT1 | |
| SCHEMBL19248901 | 0.87 | DGAT1 (0.63) | FOLH1DGAT1 | |
| SCHEMBL17706050 | 0.87 | FOLH1 (0.62) | FOLH1DGAT1 | |
| SCHEMBL16666080 | 0.87 | FOLH1 (0.62) | FOLH1DGAT1 | |
| SCHEMBL17706042 | 0.87 | DGAT1 (0.63) | FOLH1DGAT1 | |
| SCHEMBL25681677 | 0.86 | DGAT1 (0.62) | FOLH1DGAT1 | |
| SCHEMBL20979154 | 0.86 | FOLH1 (0.75) | FOLH1DGAT1 | |
| SCHEMBL17037348 | 0.85 | DGAT1 (0.65) | FOLH1DGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220396621-A1 | TARGETING AGENT ANTIBODY CONJUGATES AND USES THEREOF | SCRIPPS RESEARCH INST (US) | 2022-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220396621-A1 | TARGETING AGENT ANTIBODY CONJUGATES AND USES THEREOF | CD22, FCGR2A, CD47 | FOLH1 226/4885DGAT1 2892/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.